Exor N.V. publishes its 2025 Corporate Calendar
EXOR N.V. announced today the following Corporate Calendar for 2025:
• 26 March 2025: Board of Directors Meeting for the approval of the Company’s 2024 Annual Report
• 22 May 2025: Annual General Meeting of Shareholders for the adoption of the Company’s 2024 Financial Statements
• 17 September 2025: Board of Directors Meeting for the approval of the Company’s 2025 Half-Year Financial Report
Exor announces evolution of its early-stage venture activities
Exor announces that Noam Ohana, who has led early-stage investments at Exor, has decided to launch his own fund.
Alongside his new venture, Noam Ohana will continue to manage Exor Ventures’ €640 million portfolio for the benefit of Exor as an independent fund manager.
Exor extends its gratitude to Noam for the years of collaboration and wishes him full success in this next stage of his life as an entrepreneur and investor.
NAV reached €38.3 billion at 30 June 2024, an increase of €2.9 billion during the First Half of 2024
• NAV per share increased by 9% in the first half of 2024, compared to 14% of the MSCI World Index, mainly
driven by the performance of Ferrari, Philips and Lingotto Funds.
• Strong cash flow generation with dividends received from Companies and asset disposals of €1.5 billion.
Cash deployed into Companies, Investments and share buybacks amounted to €1.1 billion, maintaining a
disciplined capital allocation.
• Net debt was €3.7 billion at 30 June 2024 from €4.0 billion at 1 January 2024, with an LTV ratio of 9%.